Aurora Investment Counsel’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.97M | Buy |
54,746
+3,422
| +7% | +$123K | 1.04% | 43 |
|
|
2025
Q1 | $1.6M | Buy |
51,324
+597
| +1% | +$18.6K | 0.89% | 57 |
|
|
2024
Q4 | $1.29M | Buy |
50,727
+286
| +0.6% | +$7.3K | 0.71% | 74 |
|
|
2024
Q3 | $1.43M | Buy |
50,441
+512
| +1% | +$14.5K | 0.77% | 66 |
|
|
2024
Q2 | $1.32M | Buy |
49,929
+6,544
| +15% | +$173K | 0.77% | 72 |
|
|
2024
Q1 | $1.32M | Buy |
43,385
+2,827
| +7% | +$85.9K | 0.75% | 78 |
|
|
2023
Q4 | $1.59M | Buy |
40,558
+2,656
| +7% | +$104K | 1.03% | 40 |
|
|
2023
Q3 | $1.03M | Buy |
37,902
+3,572
| +10% | +$96.9K | 0.68% | 86 |
|
|
2023
Q2 | $1.06M | Sell |
34,330
-350
| -1% | -$10.8K | 0.68% | 82 |
|
|
2023
Q1 | $1.25M | Buy |
34,680
+5,020
| +17% | +$181K | 0.82% | 72 |
|
|
2022
Q4 | $1.17M | Sell |
29,660
-1,516
| -5% | -$59.9K | 0.81% | 69 |
|
|
2022
Q3 | $1.25M | Buy |
31,176
+753
| +2% | +$30.3K | 0.95% | 46 |
|
|
2022
Q2 | $1.28M | Buy |
30,423
+484
| +2% | +$20.3K | 0.92% | 43 |
|
|
2022
Q1 | $1.17M | Buy |
29,939
+257
| +0.9% | +$10K | 0.74% | 76 |
|
|
2021
Q4 | $1.18M | Buy |
29,682
+6,935
| +30% | +$276K | 0.7% | 84 |
|
|
2021
Q3 | $822K | Sell |
22,747
-50
| -0.2% | -$1.81K | 0.57% | 94 |
|
|
2021
Q2 | $934K | Buy |
+22,797
| New | +$934K | 0.65% | 80 |
|